We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Business Description Enzolytics, Inc. (the "Company" or "ENZC") is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The Company is committed to creating drugs for the better health of mankind. ENZC's flag... Business Description Enzolytics, Inc. (the "Company" or "ENZC") is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The Company is committed to creating drugs for the better health of mankind. ENZC's flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from major neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective. Show more
Small Cap Recipient of Military Drone Technology Epazz, Inc. (OTC Pink: EPAZ) is making remarkable strides with its holdings, ZenaDrone, Inc. Miami, FL -- (InvestorsHub NewsWire –...
May 3, 2023 -- InvestorsHub NewsWire -- Via Op2mst, VQC LLC -- MetaWorks Platforms, Inc. (CSE: MWRK) (OTCQB: MWRK), formerly known until last summer as CurrencyWorks appears to be...
New York, NY -- September 27, 2022 -- InvestorsHub NewsWire -- via Stock Market Press -- Stock Market Press is a leading financial news company that delivers up to date stock news. In...
New York, NY -- February 16, 2022 -- InvestorsHub NewsWire -- via Small Cap Specialists LLC -- Traders News Source, a leading independent equity research and corporate access firm focused on small...
Niche Companies in Technology, Biotech / Pharma, FinTech, Exploration, Wellness, and more in Attendance. Miami, FL -- October 11, 2021 -- InvestorsHub NewsWire -- EmergingGrowth.com...
October 11, 2021 -- InvestorsHub NewsWire -- via Prime Time Profiles -- Benzinga ClickStream Corp (OTC Other: CLIS) is in the right market at the right time. And being there at a...
CEO Presenting on the Emerging Growth Conference on Tomorrow.Β Register NowΒ Niche Companies in Technology, Cybersecurity, Exploration & Mining, and more in Attendance Β Miami, Florida August 17...
CEO Presenting on the Emerging Growth Conference on August 4.Β Register NowΒ Niche Companies in Technology, Cybersecurity, Exploration & Mining, and more in Attendance Β Miami, Florida August 2...
BEVERLY HILLS, CA -- July 28, 2021 -- InvestorsHub NewsWire -- via pennymillions -- ClickStream Corp. (OTC PINK:CLIS) a technology company focused on developing apps and digital platforms...
July 23, 2021 -- InvestorsHub NewsWire -- via StockTA.com/ALYI Alternet Systems, Inc. (ALYI) is reported today by Stock Technical Analysis (StockTA.com/ALYI) to be signaling VERY...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -5.0E-5 | -5.55555555556 | 0.0009 | 0.0011 | 0.0008 | 9753585 | 0.0008686 | CS |
4 | -5.0E-5 | -5.55555555556 | 0.0009 | 0.0019 | 0.0008 | 13946692 | 0.00116281 | CS |
12 | -0.00085 | -50 | 0.0017 | 0.0019 | 0.0008 | 12332719 | 0.00124219 | CS |
26 | -0.00115 | -57.5 | 0.002 | 0.0043 | 0.0008 | 10420152 | 0.00172585 | CS |
52 | -0.01645 | -95.0867052023 | 0.0173 | 0.0247 | 0.0008 | 11026383 | 0.00449094 | CS |
156 | -0.07115 | -98.8194444444 | 0.072 | 0.16 | 0.0008 | 9101528 | 0.03792529 | CS |
260 | 0.00035 | 70 | 0.0005 | 0.958 | 0.0001 | 26127943 | 0.06476264 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions